Lilly

Eli Lilly is a global pharmaceutical company that develops, manufactures, and markets prescription medications and vaccines. It is known for its research in areas such as diabetes, oncology, and obesity treatments.

Why it’s in the news: It is in the news for its obesity drugs, including legal battles over copycat versions and positive clinical trial results for weight loss combinations.

Latest on Lilly

• STAT+: Pharmalittle: We’re reading about a setback for Argenx, Lilly suits over copycat versions of an obesity drug, and more
• STAT+: Lilly’s Jaypirca approved as first-line CLL therapy
• STAT+: Lilly bypasses Australian pharmacies with DTC model
• STAT+: Pharmalittle: We’re reading about a plan to lower Medicare drug prices, a Lilly obesity drug, and more
• STAT+: Eli Lilly’s Zepbound combined with amylin drug led to significant weight loss in mid-stage trial
• Adding Lilly’s new drug to Zepbound helped people lose more weight — but there were more side effects

Connections

16 entities linked to Lilly across the news graph.